| Miss Michelle Lee Mehlhoff, MS,CFY-SLP | |
|
1911 N 11th St, Bismarck, ND 58501-1915 | |
| (701) 258-1569 | |
| (701) 223-1669 |
| Full Name | Miss Michelle Lee Mehlhoff |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1911 N 11th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356638282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1174 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Michelle Lee Mehlhoff, MS,CFY-SLP Po Box 2536, Bismarck, ND 58502-2536 Ph: (701) 258-1569 | Miss Michelle Lee Mehlhoff, MS,CFY-SLP 1911 N 11th St, Bismarck, ND 58501-1915 Ph: (701) 258-1569 |
News Archive
Risk prediction tools that estimate future risk of heart disease and stroke may be more useful predictors of future decline in cognitive abilities, or memory and thinking, than a dementia risk score, according to a new study published in the April 2, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.
"A new virus that emerged in the Middle East last year and has killed five people is well adapted to infecting humans but could potentially be treated with drugs that boost the immune system, scientists said on Tuesday," Reuters reports, noting, "The virus, called novel coronavirus or NCoV, is from the same family as the common cold and as SARS, or Severe Acute Respiratory Syndrome."
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company's PRINT® particle technology to design next generation malaria vaccines. PRINT technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process, and will be used to deliver a protein in combination with immune stimulating molecules.
› Verified 8 days ago
Mrs. Kelli Katharina Ellenbaum, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Sierra Larae Burgess, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 S 12th St, Bismarck, ND 58504 Phone: 701-222-3175 Fax: 701-222-3186 | |
Rebecca Mcgillivray, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 N 14th St, Bismarck, ND 58501 Phone: 701-323-4400 | |
Mrs. Karen Kaylene Davis, M. A. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1600 E Interstate Ave Ste 3, Bismarck, ND 58503 Phone: 701-751-1125 Fax: 701-751-0729 | |
Linaya Ming, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 N 19th St, Bismarck, ND 58503 Phone: 701-222-3175 Fax: 701-222-3186 | |
Donna Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 | |
Kourtney Carr, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Washington St, Bismarck, ND 58501 Phone: 701-323-4028 Fax: 701-323-4027 |